In High-Stakes Chip Deal, China Has Regulatory Leverage
A strategic struggle over tech supremacy frames Nvidia’s pending acquisition of Mellanox.
China’s Antibiotics Dominance
By some estimates, 90 percent of the world’s supply of antibiotics originate at huge factories in China.